Highland Europe led the round with participation from abrdn, Redline Capital, MMC, Hearst and GMG Ventures.
"Our vision at Signal AI is to transform business decision making through augmented intelligence. We are thrilled to have Highland Europe and abrdn join us in this latest round and appreciate the continued belief and support of our existing investors. The investment will allow us to continue to attract the best in class ML and AI product engineering talent, to scale our AIQ platform, grow our international hubs and advance the use of our decision augmentation solution with some of the world’s biggest companies."
The online learning platform raised the pre-seed round from a group led by Target Global and various angel investors.
"Our vision at Edukoya is to redefine online education for the next generation of Africans. Africa has the fastest-growing school-age population globally, with over 260M students and counting. Our goal is to democratize access and make high quality instruction and content accessible and affordable to every student, regardless of where he or she lives on the continent"
Jenson Funding Partners led the pre-seed investment round to help fund product development and expansion.
"When I first became a mother, I discovered parent tech wasn’t adapted to my needs. When I became a mum for the second time, I decided to apply my skills to develop a solution to help parents like me; those with a busy schedule who want to support their child’s development every day. As such, parents will also have access to the necessary information should they need to share it with a midwife or other health or childcare professionals."
The financing round was co-led by Boehringer Ingelheim Venture Fund and Parkwalk Advisors, with participation from Tencent and Oxford University Innovation Fund.
"Over the past decade Brainomix has created the market for stroke AI imaging. As a spin-out from the University of Oxford it is an example of the UK's world-leading strengths in life sciences and AI-enabled medtech, combining expertise in clinical care and software development with more than 150 years' experience in the field across its leadership team."
The Oxford Science Enterprises-led round will support US expansion and continued domestic growth in healthcare.
"I’m delighted our investors have again demonstrated their belief in the vast potential that Navenio can bring by ensuring ‘right person, right place, right time’. Artificial intelligence is one of many technologies making a real-world impact in the health sector, and this investment enables the company to rapidly spearhead international digital transformation."
